Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AspECT EXceL long-term follow-up study
ISRCTN14949833Phase 4Completed
- Sponsor
- University College London Comprehensive Clinical Trials Unit (UCL CCTU)
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 4, open-label trial of esomeprazole and aspirin in Barrett's esophagus (4 arms), sponsored by University College London Comprehensive Clinical Trials Unit (UCL CCTU). Started Jul 2023; status: completed.
02
Drugs
esomeprazoleaspirin
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on ISRCTN14949833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14949833.